[19] Los agonistas del receptor GLP-1, como la semaglutida y la liraglutida, suelen causar efectos adversos gastrointestinales como nuseas, vmitos, diarrea, estreimiento y molestias abdominales, especialmente durante el aumento de la dosis
For individuals with genetic variations affecting GLP-1 receptor sensitivity or peptide metabolism, diet and exercise alone may be insufficient
If you're camera-shy, we can complete your medical consultation over the phone instead of video
Mi R, Cheng H, Chen R, Bai B, Li A, Gao F, Xue G
Patients should disclose a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, kidney disease or dehydration risk, use of diabetes medications such as insulin or sulfonylureas, pregnancy or plans for pregnancy, and any personal or family history of medullary thyroid carcinoma or MEN2
But where you get your medication from matters, says Orlando Health Weight Loss and Bariatric Surgery Institute's medical director Dr